Vir Biotechnology, Inc. VIR EPS (Diluted)
EPS (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Vir Biotechnology, Inc. in its filing.
Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.
The official record: Vir Biotechnology, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Vir Biotechnology, Inc.'s eps (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Vir Biotechnology, Inc.'s EPS (diluted)?
- Vir Biotechnology, Inc. (VIR) reported EPS (diluted) of -$0.85 in Q1 2026.
- How has Vir Biotechnology, Inc.'s EPS (diluted) changed year-over-year?
- Vir Biotechnology, Inc.'s EPS (diluted) increased by 3.4% year-over-year, from -$0.88 to -$0.85.
- What is the long-term trend for Vir Biotechnology, Inc.'s EPS (diluted)?
- Over 3 years (2021 to 2025), Vir Biotechnology, Inc.'s EPS (diluted) has grown at a -6.9% compound annual growth rate (CAGR), from $3.90 to -$3.15.
- What does EPS (diluted) mean?
- Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.